CFDE Data Portal | Search PPIAP91

	Label	Description
	PPIAP91 Gene (Entity type)	ENSG00000228728 - peptidylprolyl isomerase A pseudogene 91
	GSE222758 clofazimine U2OS 0 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE173201 cisplatin 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE178267 vemurafenib 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 14 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Testis 20-29 vs 30-39 Up Gene Set (Entity type)	A Gene Set from GTEx
	GSE205556 bexarotene 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE99503 GSK3 TUNAR inhibition B cell 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

PPIAP91

ENSG00000228728 - peptidylprolyl isomerase A pseudogene 91

GSE222758 clofazimine U2OS 0 v 4 human up

A Gene Set from LINCS

GSE173201 cisplatin 2 v 3 human dn

A Gene Set from LINCS

GSE178267 vemurafenib 2 v 0 human up

A Gene Set from LINCS

GSE233679 nicotinamide 14 v 4 human dn

A Gene Set from LINCS

GTEx Testis 20-29 vs 30-39 Up

A Gene Set from GTEx

GSE205556 bexarotene 1 v 0 human dn

A Gene Set from LINCS

GSE99503 GSK3 TUNAR inhibition B cell 0 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.